Rhenium-188-labeled DTPA: a new radiopharmaceutical for intravascular radiation therapy
- 1 November 1999
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 26 (8) , 967-972
- https://doi.org/10.1016/s0969-8051(99)00074-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Endovascular beta irradiation for prevention of restenosis using solution radioisotopesCardiovascular Radiation Medicine, 1999
- Intracoronary Radiation for Prevention of RestenosisCirculation, 1998
- Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorateNuclear Medicine Communications, 1998
- The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicineInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1986
- Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty.Circulation, 1985
- Clinically important radiation-associated thyroid disease. A controlled studyPublished by American Medical Association (AMA) ,1980
- The relationship of head and neck irradiation to the subsequent development of thyroid neoplasmsSeminars in Nuclear Medicine, 1976
- Thyroid Cancer Occurring as a Late Consequence of Head-and-Neck IrradiationNew England Journal of Medicine, 1976
- Radiation Nephritis: A ReviewJournal of Urology, 1975
- Dose to the Fetus from Radionuclides in the BladderHealth Physics, 1973